These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22923701)

  • 1. Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda.
    Wagner GJ; Ghosh-Dastidar B; Garnett J; Kityo C; Mugyenyi P
    Psychosom Med; 2012; 74(9):883-90. PubMed ID: 22923701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression in the pathway of HIV antiretroviral effects on sexual risk behavior among patients in Uganda.
    Wagner GJ; Ghosh-Dastidar B; Holloway IW; Kityo C; Mugyenyi P
    AIDS Behav; 2012 Oct; 16(7):1862-9. PubMed ID: 21986868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa.
    Peltzer K; Ramlagan S
    AIDS Care; 2011 Jan; 23(1):60-8. PubMed ID: 21218277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study.
    Olley BO; Seedat S; Stein DJ
    J Psychosom Res; 2006 Oct; 61(4):479-84. PubMed ID: 17011355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "The way I see it": the effect of stigma and depression on self-perceived body image among HIV-positive individuals on treatment in British Columbia, Canada.
    Palmer AK; Duncan KC; Ayalew B; Zhang W; Tzemis D; Lima V; Montaner JS; Hogg RS
    AIDS Care; 2011 Nov; 23(11):1456-66. PubMed ID: 21767109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Impact of Food Assistance on Stigma Among People Living with HIV in Uganda Using the HIV/AIDS Stigma Instrument-PLWA (HASI-P).
    Maluccio JA; Wu F; Rokon RB; Rawat R; Kadiyala S
    AIDS Behav; 2017 Mar; 21(3):766-782. PubMed ID: 27372803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda.
    Bajunirwe F; Tisch DJ; King CH; Arts EJ; Debanne SM; Sethi AK
    AIDS Care; 2009 Mar; 21(3):271-9. PubMed ID: 19280404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy.
    Galli M; Ridolfo AL; Adorni F; Cappelletti A; Morelli P; Massetto B; Piazza M; Gianelli E; Vaccarezza M; Gervasoni C; Moroni M
    Antivir Ther; 2003 Aug; 8(4):347-54. PubMed ID: 14518704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and CD4 cell count among persons with HIV infection in Uganda.
    Kaharuza FM; Bunnell R; Moss S; Purcell DW; Bikaako-Kajura W; Wamai N; Downing R; Solberg P; Coutinho A; Mermin J
    AIDS Behav; 2006 Jul; 10(4 Suppl):S105-11. PubMed ID: 16802195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
    Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
    HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safer sexual behaviours after 1 year of antiretroviral treatment in KwaZulu-Natal, South Africa: a prospective cohort study.
    Peltzer K; Ramlagan S
    Sex Health; 2010 Jun; 7(2):135-41. PubMed ID: 20465976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda.
    Wagner GJ; Ngo VK; Nakasujja N; Akena D; Aunon F; Musisi S
    Int J Psychiatry Med; 2014; 48(3):155-66. PubMed ID: 25492710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
    Greig J; Casas EC; O'Brien DP; Mills EJ; Ford N
    AIDS; 2012 Jul; 26 Suppl 1():S31-7. PubMed ID: 22781173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa.
    Wouters E; Van Loon F; Van Rensburg D; Meulemans H
    AIDS Care; 2009 Nov; 21(11):1401-11. PubMed ID: 20024717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting.
    Mills EJ; Bakanda C; Birungi J; Yaya S; Ford N;
    AIDS; 2012 Jul; 26(11):1425-9. PubMed ID: 22526520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.